BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohan S, Iltis AS, Sawinski D, DuBois JM. APOL1 Genetic Testing in Living Kidney Transplant Donors. Am J Kidney Dis 2019;74:538-43. [PMID: 30982552 DOI: 10.1053/j.ajkd.2019.02.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Harris DD, Fleishman A, Pavlakis M, Pollak MR, Baliga PK, Rohan V, Kayler LK, Rodrigue JR. Apolipoprotein L1 Opinions of African American Living Kidney Donors, Kidney Transplant Patients, and Nonpatients. J Surg Res 2022;277:116-24. [PMID: 35489216 DOI: 10.1016/j.jss.2022.04.011] [Reference Citation Analysis]
2 Arabi Z, Bukhari M, Hamad A, Altheaby A, Kaysi S. Practice Patterns in the Acceptance of Medically Complex Living Kidney Donors with Obesity, Hypertension, Family History of Kidney Disease, or Donor-Recipient Age Discrepancy. Avicenna J Med 2021;11:172-84. [PMID: 34881200 DOI: 10.1055/s-0041-1736541] [Reference Citation Analysis]
3 Nestor JG, Li AJ, King KL, Husain SA, McIntosh TJ, Sawinski D, Iltis AS, Goodman MS, Walsh HA, DuBois JM, Mohan S. Impact of education on APOL1 testing attitudes among prospective living kidney donors. Clin Transplant 2021;:e14516. [PMID: 34661305 DOI: 10.1111/ctr.14516] [Reference Citation Analysis]
4 Iltis AS, Connell A, Cooper L, Gee PO, Jefferson NM, Johnson HA, Kingston GM, Roberts GV, Scott N, Smith A, Waddy S, Woodard L, DuBois JM. Improving Kidney Disease Research in the Black Community: The Essential Role of Black Voices in the APOLLO Study. Am J Kidney Dis 2021:S0272-6386(21)00916-1. [PMID: 34653538 DOI: 10.1053/j.ajkd.2021.09.006] [Reference Citation Analysis]
5 Thomas CP, Gupta S, Freese ME, Chouhan KK, Dantuma MI, Holanda DG, Katz DA, Darbro BW, Mansilla MA, Smith RJ. Sequential genetic testing of living-related donors for inherited renal disease to promote informed choice and enhance safety of living donation. Transpl Int 2021. [PMID: 34632641 DOI: 10.1111/tri.14133] [Reference Citation Analysis]
6 Lopez-Soler RI, Garcia-Roca R, Lee DD. Disparities in living donation. Curr Opin Organ Transplant 2021;26:542-6. [PMID: 34375319 DOI: 10.1097/MOT.0000000000000912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lentine KL, Mannon RB. Apolipoprotein L1: role in the evaluation of kidney transplant donors. Curr Opin Nephrol Hypertens 2020;29:645-55. [PMID: 33009133 DOI: 10.1097/MNH.0000000000000653] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
8 Freedman BI, Poggio ED. APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro). Kidney Int 2021;100:27-30. [PMID: 34154719 DOI: 10.1016/j.kint.2020.11.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kasiske BL, Ahn YS, Conboy M, Dew MA, Folken C, Levan M, Israni AK, Lentine KL, Matas AJ, Newell KA, LaPointe Rudow D, Massie AB, Musgrove D, Snyder JJ, Taler SJ, Wang J, Waterman AD. Outcomes of Living Kidney Donor Candidate Evaluations in the Living Donor Collective Pilot Registry. Transplant Direct 2021;7:e689. [PMID: 33912656 DOI: 10.1097/TXD.0000000000001143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Husain SA, King KL, Sanichar N, Crew RJ, Schold JD, Mohan S. Association Between Donor-Recipient Biological Relationship and Allograft Outcomes After Living Donor Kidney Transplant. JAMA Netw Open 2021;4:e215718. [PMID: 33847748 DOI: 10.1001/jamanetworkopen.2021.5718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Berrigan M, Austrie J, Fleishman A, Tercyak KP, Pollak MR, Pavlakis M, Rohan V, Baliga PK, Kayler LK, Feeley TH, Rodrigue JR. Opinions of African American adults about the use of apolipoprotein L1 (ApoL1) genetic testing in living kidney donation and transplantation. Am J Transplant 2021;21:1197-205. [PMID: 32659871 DOI: 10.1111/ajt.16206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
12 Morris H, Mohan S. Using race in the estimation of glomerular filtration rates: time for a reversal? Curr Opin Nephrol Hypertens 2020;29:227-31. [PMID: 31895163 DOI: 10.1097/MNH.0000000000000587] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Gill JS, Brar S. Surveys are sometimes most notable for what they do not tell us. Am J Transplant 2020;20:3279-80. [PMID: 32506602 DOI: 10.1111/ajt.16115] [Reference Citation Analysis]
14 McIntosh T, Mohan S, Sawinski D, Iltis A, DuBois JM. Variation of ApoL1 Testing Practices for Living Kidney Donors. Prog Transplant 2020;30:22-8. [PMID: 31838940 DOI: 10.1177/1526924819892917] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
15 Freedman BI, Moxey-Mims MM, Alexander AA, Astor BC, Birdwell KA, Bowden DW, Bowen G, Bromberg J, Craven TE, Dadhania DM, Divers J, Doshi MD, Eidbo E, Fornoni A, Gautreaux MD, Gbadegesin RA, Gee PO, Guerra G, Hsu CY, Iltis AS, Jefferson N, Julian BA, Klassen DK, Koty PP, Langefeld CD, Lentine KL, Ma L, Mannon RB, Menon MC, Mohan S, Moore JB, Murphy B, Newell KA, Odim J, Ortigosa-Goggins M, Palmer ND, Park M, Parsa A, Pastan SO, Poggio ED, Rajapakse N, Reeves-Daniel AM, Rosas SE, Russell LP, Sawinski D, Smith SC, Spainhour M, Stratta RJ, Weir MR, Reboussin DM, Kimmel PL, Brennan DC. APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale. Kidney Int Rep 2020;5:278-88. [PMID: 32154449 DOI: 10.1016/j.ekir.2019.11.022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
16 Neugut YD, Mohan S, Gharavi AG, Kiryluk K. Cases in Precision Medicine: APOL1 and Genetic Testing in the Evaluation of Chronic Kidney Disease and Potential Transplant. Ann Intern Med 2019;171:659-64. [PMID: 31590185 DOI: 10.7326/M19-1389] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
17 Nestor J, Mohan S. A Focus on APOL1 and Kidney Disease. Kidney Int Rep 2019;4:901-3. [PMID: 31312770 DOI: 10.1016/j.ekir.2019.05.1158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]